Małgorzata Krajnik

Prof. Małgorzata Krajnik


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2017 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
APAnna Pyszora
Anna Pyszora
JBJacek Budzyński
Jacek Budzyński
AWAgnieszka Wójcik
Agnieszka Wójcik
APAnna Prokop
Anna Prokop
MKMałgorzata Krajnik
Małgorzata Krajnik
Purpose Cancer-related fatigue (CRF) is a common and relevant symptom in patients with advanced cancer that significantly decreases their quality of life. The aim of this study was to evaluate the effect of a physiotherapy programme on CRF and other symptoms in patients diagnosed with advanced cancer. Methods The study was designed as a randomized controlled trial. Sixty patients diagnosed with advanced cancer receiving palliative care were randomized into two groups: the treatment group (n = 30) and the control group (n = 30). The therapy took place three times a week for 2 weeks. The 30-min physiotherapy session included active exercises, myofascial release and proprioceptive neuromuscular facilitation (PNF) techniques. The control group did not exercise. The outcomes included Brief Fatigue Inventory (BFI), Edmonton Symptom Assessment Scale (ESAS) and satisfaction scores. Results The exercise programme caused a significant reduction in fatigue scores (BFI) in terms of severity of fatigue and its impact on daily functioning. In the control group, no significant changes in the BFI were observed. Moreover, the physiotherapy programme improved patients’ general well-being and reduced the intensity of coexisting symptoms such as pain, drowsiness, lack of appetite and depression. The analysis of satisfaction scores showed that it was also positively evaluated by patients. Conclusion The physiotherapy programme, which included active exercises, myofascial release and PNF techniques, had beneficial effects on CRF and other symptoms in patients with advanced cancer who received palliative care. The results of the study suggest that physiotherapy is a safe and effective method of CRF management.

1 January 2010 in Pharmacological Reports
Verified
Journal Article
Closed access
MKMałgorzata Krajnik
Małgorzata Krajnik
MSMichael Schäfer
Michael Schäfer
PSPiotr Sobański
Piotr Sobański
JKJanusz Kowalewski
Janusz Kowalewski
EBElżbieta Bloch-Bogusławska
Elżbieta Bloch-Bogusławska
SMShaaban A. Mousa
Shaaban A. Mousa

1 November 2009 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
MKMałgorzata Krajnik
Małgorzata Krajnik
ZPZygmunt Podolec
Zygmunt Podolec
MSMonika Siekierka
Monika Siekierka
MSMarzena Sykutera
Marzena Sykutera
EPEwa Pufal
Ewa Pufal
ZZZbigniew Zylicz
Zbigniew Zylicz

14 March 2010 in BioMedical Engineering OnLine
Verified
Journal Article
Open access
PDF file
MKMałgorzata Krajnik
Małgorzata Krajnik
IDIwona Damps-Konstanska
Iwona Damps-Konstanska
LGLucyna Gorska
Lucyna Gorska
EJEwa Jassem
Ewa Jassem
Background: Cough is one of the main symptoms of advanced lung disease. However, the efficacy of currently available treatment remains unsatisfactory. Research into the new antitussives requires an objective assessment of cough. Methods: The aim of the study was to test the feasibility of a new automatic portable cough analyser and assess the correlation between subjective and objective evaluations of cough in 13 patients with chronic cough. The patients' individual histories, a cough symptom score and a numeric cough scale (1-10) were used as a subjective evaluation of cough and a computerized audio-timed recorder was used to measure the frequency of coughing. Results: The pre-clinical validation has shown that an automated cough analyser is an accurate and reliable tool for the ambulatory assessment of chronic cough. In the clinical part of the experiment for the daytime, subjective cough scoring correlated with the number of all cough incidents recorded by the cough analyser (r = 0.63; p = 0.022) and the number of cough incidents per hour (r = 0.60; p = 0.03). However, there was no relation between cough score and the time spent coughing per hour (r = 0.48; p = 0.1). As assessed for the night-time period, no correlation was found between subjective cough scoring and the number of incidents per hour (r = 0.29; p = 0.34) or time spent coughing (r = 0.26; p = 0.4). Conclusion: An automated cough analyser seems to be a feasible tool for the ambulatory monitoring of cough. There is a moderate correlation between subjective and objective assessments of cough during the daytime, whereas the discrepancy in the evaluation of night-time coughing might suggest that subjective analysis is unreliable.

11 December 2017 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
PJPiotr Janowiak
Piotr Janowiak
MKMałgorzata Krajnik
Małgorzata Krajnik
ZPZygmunt Podolec
Zygmunt Podolec
TBTomasz Bandurski
Tomasz Bandurski
IDIwona Damps-Konstanska
Iwona Damps-Konstanska
EJEwa Jassem
Ewa Jassem
Systemic morphine has evidence to support its use for reducing breathlessness in patients with severe chronic obstructive pulmonary disease (COPD). The effectiveness of the nebulized route, however, has not yet been confirmed. Recent studies have shown that opioid receptors are localized within epithelium of human trachea and large bronchi, a target site for a dosimetric nebulizer. The aim of this study was to compare any clinical or statistical differences in breathlessness intensity between nebulized 2.0% morphine and 0,9% NaCl in patients with very severe COPD. The study was a double-blind, controlled, cross-over trial. Participants received morphine or NaCl during two 4-day periods. Sequence of periods was randomized. The primary outcome measure was reduction of breathlessness intensity now by ≥20 mm using a 100 mm visual analogue scale (VAS) at baseline, 15, 30, 60, 120, 180 and 240 min after daily administration, during normal activities. Ten of 11 patients included completed the study protocol. All patients experienced clinically and statistically significant (p < 0.0001) breathlessness reduction during morphine nebulization. Mean VAS changes for morphine and 0.9% NaCl periods were 25.4 mm (standard deviation (SD): 9.0; median: 23,0; range: 14.0 to 41,5; confidence interval (CI): 95%) and 6.3 mm (SD: 7.8; median: 6.8; range: −11,5 to 19,5; CI: 95%), respectively. No treatment emergent adverse effects were noted. Our study showed superiority of dosimetrically administered nebulized morphine compared to NaCl in reducing breathlessness. This may have been achieved through morphine’s direct action on receptors in large airways, although a systemic effect from absorption through the lungs cannot be excluded. Retrospectively registered (07.03.2017), ISRCTN14865597

26 July 2022 in Journal of Religion and Health
Verified
Journal Article
Open access
PDF file
MFMałgorzata Fopka-Kowalczyk
Małgorzata Fopka-Kowalczyk
MBMegan Best
Megan Best
MKMałgorzata Krajnik
Małgorzata Krajnik
This study aimed to design, validate and standardize the Spiritual Supporter (SpSup) Scale, a tool designed to assess competency to provide spiritual care including knowledge, sensitivity to spiritual needs and spiritual support skills. This instrument can be used by all those engaged in or training for caregiving roles. The study was conducted in Poland in the Polish language. The SpSup Scale demonstrates high overall reliability (Cronbach’s α = 0.88), a satisfactory diagnostic accuracy (0.79), and a satisfactory discriminatory power of the items. Given the psychometric properties of SpSup Scale demonstrated here, the scale is recommended for the assessment of the competency to provide spiritual care in both clinical and research settings in Poland.